Concepedia

Stephen M. F. Jamieson

SM

Statistics

Publications

78

Citations

3.3K

H-Index

35

Active since

2003

Affiliations

University of Auckland(Current)

Cancer Society of New Zealand

Maurice Wilkins Centre

University of Sargodha

University of Otago

Stephen M. F. Jamieson is an author at University of Auckland specializing in pharmacology, medicinal chemistry, and cancer pharmacology.

ORCID

Publications per year

2003–2023

78

Publications

78

Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer

Khine Nyein Myint, Riya Biswas, Yan Li et al. · Scientific Reports · 2019 · 262 citations · Full text

, , +14

A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types

Stephen M. F. Jamieson, Jack U. Flanagan, Sharada Kolekar et al. · Biochemical Journal · 2011 · 172 citations · Full text

, , +14

A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth <i>In vitro</i> and <i>In vivo</i>

Kuzhuvelil B. Harikumar, Ajaikumar B. Kunnumakkara, Nobuo Ochi et al. · Molecular Cancer Therapeutics · 2010 · 172 citations · Full text

, , +17

Impact of the Halogen Substitution Pattern on the Biological Activity of Organoruthenium 8-Hydroxyquinoline Anticancer Agents

Mario Kubanik, Hannah U. Holtkamp, Tilo Söhnel et al. · Organometallics · 2015 · 162 citations · Full text

, , +15

Synthesis and Biological Evaluation of Novel Analogues of the Pan Class I Phosphatidylinositol 3-Kinase (PI3K) Inhibitor 2-(Difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1<i>H</i>-benzimidazole (ZSTK474)

Gordon W. Rewcastle, Swarna A. Gamage, Jack U. Flanagan et al. · Journal of Medicinal Chemistry · 2011 · 103 citations · Full text

, , +15

1–5 of 78